MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Gliomatosis cerebri

(UMLS:C0334576)

UMLS ID:: C0334576
MeSH ID:: D018302

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.600|C04.557.470.670|C04.557.580.625.600

Synonym(s)

Gliomatosis cerebri

Astrocytosis cerebri

Gliomatosis

Gliomatosis Cerebri

gliomatosis; cerebri

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Fingolimod Hydrochloride	FAERS: 1		US FAERS
2	Ticagrelor	FAERS: 1		US FAERS

Similar ADE(s)

	Name	Semantic Similarity
1	Craniopharyngioma	58.4%
2	Neuroectodermal Tumor, Melanotic	58.4%
3	Neuroendocrine Tumors	58.4%
4	Adenoma, Acidophil	54.8%
5	melanoma	53.5%
6	Carcinoid Tumor	51.2%
7	Neurilemmoma	49.1%
8	Paraganglioma	44.5%
9	Malignant Carcinoid Syndrome	43.7%
10	Basal cell carcinoma	42.9%
11	Carcinoma, Papillary	42.9%
12	Squamous cell carcinoma	42.9%
13	Cystadenoma	42.9%
14	Mesothelioma	42.9%
15	Carcinoma, Basal Cell	42.9%
16	Hutchinson's Melanotic Freckle	42.6%
17	Melanoma, Amelanotic	42.6%
18	leukemia	40%
19	Melanoma, Experimental	38.9%
20	Cystadenocarcinoma	38.5%
21	Mucoepidermoid Carcinoma	38.5%
22	Adenoma	37.7%
23	Carcinoma	37.7%
24	Epithelioma	37.7%
25	Pheochromocytoma	37.6%
26	Meningioma	36.1%
27	Carcinoid Heart Disease	34.7%
28	Chordoma	34.4%
29	Teratoma	34.4%
30	Germinoma	34.4%
31	Teratocarcinoma	34.4%
32	Bowen's Disease	34.2%
33	Carcinosarcoma	33.3%
34	Hemangiosarcoma	33.3%
35	lymphangiosarcoma	33.3%
36	Carcinoma, Ehrlich Tumor	32.5%
37	Carcinoma, Lewis Lung	32.5%
38	Carcinoma, Lobular	32.3%
39	Trophoblastic Neoplasms	32.2%
40	Histiocytic Disorders, Malignant	32%
41	Adenofibroma	30.5%
42	Fibroadenoma	30.5%
43	Choriocarcinoma	30.4%
44	Dermoid Cyst	29.8%
45	Carcinoma 256, Walker	29.3%
46	Acanthoma	28.1%
47	Composite Lymphoma	28%
48	Leukemia, Plasma Cell	27.7%
49	Neuroectodermal Tumors	27.6%
50	Neoplasms, Germ Cell and Embryonal	27.5%
51	Germ Cell Cancer	27.5%
52	Chondrosarcoma	27.3%
53	leiomyosarcoma	27.3%
54	liposarcoma	27.3%
55	synovial sarcoma	27.3%
56	Angiomyolipoma	27.3%
57	Clear Cell Sarcoma of Soft Tissue	27.3%
58	Alveolar Soft Part Sarcoma	27.3%
59	Sarcoma, Myeloid	27.3%
60	Adenocarcinoma	26.8%
61	Carcinoma in Situ	26.8%
62	Carcinoma, Transitional Cell	26.8%
63	Papilloma	26.8%
64	Pseudomyxoma Peritonei	26.8%
65	Papillomatosis	26.8%
66	Adenomatosis, Pulmonary	26.8%
67	Adenomatous Polyps	26.8%
68	Carcinoma, Large Cell	26.8%
69	Carcinoma, Small Cell	26.8%
70	Lymphoma	26.7%
71	Neoplasms, Neuroepithelial	26.1%
72	Gliomatosis cerebri	26.1%
73	Leukemia, Experimental	25.4%
74	Neoplasms, Glandular and Epithelial	25%
75	Ameloblastoma	24.6%
76	Angiokeratoma	24.6%
77	Hemangioma	24.6%
78	hemangiopericytoma	24.6%
79	Lymphangioma	24.6%
80	Mesenchymoma	24.6%
81	Nevus	24.6%
82	Hepatoblastoma	24.6%
83	Mixed Tumor, Mullerian	24.6%
84	Angiofibroma	24.6%
85	Sarcoma	24.6%
86	Acoustic Neuroma	24.5%
87	Fibrosarcoma	24.3%
88	Osteosarcoma	24.3%
89	Hamartoma	24.1%
90	Neoplasms, Hormone-Dependent	24.1%
91	Neoplasms, Multiple Primary	24.1%
92	Paraneoplastic Syndromes	24.1%
93	Precancerous Conditions	24.1%
94	Neoplasms, Second Primary	24.1%
95	Dysgerminoma	23.6%
96	Neuroma	23.6%
97	Seminoma	23.6%
98	Malignant Fibrous Histiocytoma	22.8%
99	Leukemia, Radiation-Induced	22%
100	Adenoid Cystic Carcinoma	21.5%
101	Adenocarcinoma, Clear Cell	21.5%
102	Cholangiocarcinoma	21.5%
103	Cervical Intraepithelial Neoplasia	21.5%
104	Endometrial Stromal Sarcoma	21.4%
105	Neurofibrosarcoma	21.3%
106	Rhabdomyosarcoma	21.3%
107	Giant Cell Tumor of Bone	21.3%
108	Medulloblastoma	21.3%
109	Carcinoma, Pancreatic Ductal	20.7%
110	Vipoma	20.4%
111	Sarcoma, Experimental	20.3%
112	Basal Cell Nevus Syndrome	20.3%
113	Leukemia L1210	20.3%
114	Leukemia P388	20.3%
115	Thymoma	20.2%
116	Dermatofibrosarcoma	19.8%
117	Dermatofibrosarcoma Protuberans	19.8%
118	Plasmacytoma	19.7%
119	Malignant histiocytosis	19.6%
120	Histiocytic sarcoma	19.6%
121	Cyst	19.4%
122	Neoplastic Processes	19.4%
123	Neoplastic Syndromes, Hereditary	19.4%
124	Pregnancy Complications, Neoplastic	19.4%
125	Lymphangioleiomyomatosis	19.4%
126	Ganglioneuroma	19.4%
127	Glioma	19.4%
128	Malignant Glioma	19.4%
129	Neoplasms, Experimental	19.2%
130	Klatskin Tumor	18.8%
131	Hepatocellular Adenoma	18.7%
132	Alveolar rhabdomyosarcoma	18.3%
133	Multiple Endocrine Neoplasia	17.8%
134	Sarcoma 180	17.3%
135	Phyllodes Tumor	17.1%
136	Hemangioendothelioma	17.1%
137	Lipoma	17.1%
138	Myoma	17.1%
139	Myxoma	17.1%
140	Angiolipoma	17.1%
141	Myelolipoma	17.1%
142	Neoplasms, Bone Tissue	17.1%
143	Neoplasms, Fibrous Tissue	17.1%
144	Smooth Muscle Tumor	17.1%
145	Desmoplastic Small Round Cell Tumor	17.1%
146	Chondroma	17.1%
147	Enchondroma	17.1%
148	Hodgkin Disease	16.3%
149	Lymphoma, Non-Hodgkin	16.3%
150	Prolactinoma	16.3%
151	Growth Hormone-Secreting Pituitary Adenoma	16.3%
152	Astrocytoma	16%
153	Ependymoma	16%
154	oligodendroglioma	16%
155	Ganglioglioma	16%
156	gliosarcoma	16%
157	Anaplastic astrocytoma	16%
158	Anaplastic Oligodendroglioma	16%
159	Neoplasms, Radiation-Induced	16%
160	Hydatidiform Mole	15.9%
161	neurofibroma	15.6%
162	Nephroblastoma	15.3%
163	Lymphomatoid Granulomatosis	15.1%
164	Paraneoplastic Encephalomyelitis	14.6%
165	Glioblastoma	14.4%
166	Neuroblastoma	14.4%
167	Glioblastoma Multiforme	14.4%
168	Carcinoma, Ovarian Epithelial	14.4%
169	Mammary Neoplasms, Experimental	14.4%
170	Retinoblastoma	14.1%
171	Primary amyloidosis	14.1%
172	Leukemia, Myelomonocytic, Chronic	13.6%
173	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	13.6%
174	Ganglioneuroblastoma	13.6%
175	Tuberous Sclerosis	13.5%
176	insulinoma	13.4%
177	fibroma	13.4%
178	Fibromatosis	13.4%
179	Osteoblastoma	13.4%
180	Osteoma	13.4%
181	Rhabdomyoma	13.4%
182	Chondromatosis	13.4%
183	Hemangioblastoma	13.4%
184	Lymphoma, Extranodal NK-T-Cell	13.4%
185	Abdominal Neoplasms	13.3%
186	Erythroplasia	13.3%
187	Follicular cyst	13.3%
188	Head and Neck Neoplasms	13.3%
189	Mucocele	13.3%
190	Pilonidal Cyst	13.3%
191	Soft Tissue Neoplasms	13.3%
192	Thoracic Neoplasms	13.3%
193	Thyroglossal Cyst	13.3%
194	Synovial Cyst	13.3%
195	Aberrant Crypt Foci	13.3%
196	Adrenocortical carcinoma	12.9%
197	Adenomatous Polyposis Coli	12.8%
198	Mesoblastic Nephroma	12.7%
199	Gastrinoma	12.2%
200	Glucagonoma	12.2%
201	Nasopharyngeal carcinoma	12.2%
202	Mastocytosis	11.6%
203	Sturge-Weber Syndrome	11.6%
204	Fibromatosis, Aggressive	11.5%
205	Fibromatosis, Abdominal	11.5%
206	Gastrointestinal Stromal Tumors	11.5%
207	Renal Cell Carcinoma	11.4%
208	Papillary Renal Cell Carcinoma	11.4%
209	Hemangioma, Cavernous	11.4%
210	Leukemia, T-Cell	11.4%
211	Leukemia, B-Cell	11.4%
212	Lymphoma, Follicular	11.3%
213	T-Cell Lymphoma	11.3%
214	Mantle cell lymphoma	11.3%
215	Digestive System Neoplasms	11.1%
216	Endocrine Gland Neoplasms	11.1%
217	Eye Neoplasms	11.1%
218	Nervous System Neoplasms	11.1%
219	Carcinoma, Endometrioid	11.1%
220	Multiple Endocrine Neoplasia Type 1	11.1%
221	Waldenstrom Macroglobulinemia	10.9%
222	Multiple Myeloma	10.9%
223	Bone neoplasms	10.8%
224	Leukoplakia	10.8%
225	Lymphocele	10.8%
226	Pancreatic Cyst	10.8%
227	Skin Neoplasms	10.8%
228	Hematologic Neoplasms	10.8%
229	Mastocytoma	10.7%
230	Mastocytosis, Systemic	10.7%
231	Barrett Esophagus	10.7%
232	Breast Cyst	10.7%
233	Actinic keratosis	10.7%
234	Mediastinal Cyst	10.7%
235	Neoplasm Invasiveness	10.7%
236	Neoplasm Metastasis	10.7%
237	Neoplasm Recurrence, Local	10.7%
238	Parovarian Cyst	10.7%
239	Pericardial Cyst	10.7%
240	Splenic Neoplasms	10.7%
241	Thymic Cyst	10.7%
242	Carcinogenesis	10.7%
243	Myxoid cyst	10.7%
244	Metastasis	10.7%
245	Leukemia, Myeloid, Chronic-Phase	10.6%
246	granulosa cell tumor	10.1%
247	Optic Nerve Glioma	9.9%
248	Parathyroid Neoplasms	9.6%
249	Peritoneal Neoplasms	9.6%
250	Thyroid Neoplasm	9.6%
251	Thyroid carcinoma	9.6%
252	Liver Neoplasms, Experimental	9.5%
253	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	8.8%
254	Leukemia, Large Granular Lymphocytic	8.8%
255	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	8.8%
256	Lymphoma, T-Cell, Cutaneous	8.8%
257	Lymphoma, AIDS-Related	8.8%
258	Enteropathy-Associated T-Cell Lymphoma	8.8%
259	Primary Effusion Lymphoma	8.8%
260	Corpus Luteum Cyst	8.8%
261	Ovarian Cysts	8.8%
262	Leydig Cell Tumor	8.6%
263	Pancreatic Neoplasm	8.5%
264	Retroperitoneal Neoplasms	8.2%
265	Tracheal Neoplasms	8.1%
266	Leukoplakia, Oral	8%
267	Paraneoplastic Cerebellar Degeneration	7.9%
268	Dupuytren Contracture	7.8%
269	Urticaria Pigmentosa	7.7%
270	Choledochal Cyst	7.7%
271	Denys-Drash Syndrome	7.7%
272	Mycosis Fungoides	7.6%
273	Lymphomatoid Papulosis	7.6%
274	Plasmablastic lymphoma	7.6%
275	Peutz-Jeghers Syndrome	7.5%
276	Esophageal Neoplasms	7%
277	Limbic Encephalitis	6.9%
278	Mouth Neoplasms	6.7%
279	Central Nervous System Neoplasms	6.7%
280	Vascular Neoplasms	6.7%
281	Thymus Neoplasms	6.7%
282	Burkitt Lymphoma	6.7%
283	Genital Neoplasms, Female	6.6%
284	Pancreatic Pseudocyst	6.6%
285	Thyroid Nodule	6.5%
286	Lymphatic Metastasis	6.5%
287	Neoplasms, Unknown Primary	6.5%
288	Leukemic Infiltration	6.5%
289	Breast Neoplasms, Male	6.5%
290	Neoplasm Micrometastasis	6.5%
291	Triple Negative Breast Neoplasms	6.5%
292	Lambert-Eaton Myasthenic Syndrome	6.3%
293	Testicular Neoplasms	6.3%
294	Sezary Syndrome	5.8%
295	Opsoclonus-Myoclonus Syndrome	5.6%
296	Adrenal Gland Neoplasms	5.6%
297	Gastrointestinal Neoplasms	5.6%
298	Genital Neoplasms, Male	5.6%
299	Liver neoplasms	5.6%
300	Uveal Neoplasms	5.6%
301	Urologic Neoplasms	5.6%
302	Sebaceous Gland Neoplasms	5.5%
303	Spinal Neoplasms	5.5%
304	Bone Marrow Neoplasms	5.5%
305	Polycystic Ovary Syndrome	5.4%
306	Myelitis, Transverse	5.1%
307	Xeroderma Pigmentosum	4.8%
308	Nose Neoplasms	4.7%
309	Meningeal Neoplasms	4.6%
310	Palatal Neoplasms	4.5%
311	Pituitary Adenoma	4.3%
312	Pituitary Neoplasms	4.3%
313	ovarian neoplasm	4.1%
314	Ear Neoplasms	3.9%
315	Eyelid Neoplasms	3.9%
316	Lung Neoplasms	3.9%
317	Pleural Neoplasms	3.9%
318	Cell Transformation, Viral	3.8%
319	Brain Neoplasms	3.8%
320	Salivary Gland Neoplasms	3.8%
321	Spinal Cord Neoplasms	3.8%
322	Tongue Neoplasms	3.8%
323	Uterine Neoplasms	3.8%
324	Vaginal Neoplasms	3.8%
325	Vulvar Neoplasms	3.8%
326	Uterine Cancer	3.8%
327	Fallopian Tube Neoplasms	3.8%
328	Meningeal Carcinomatosis	3.6%
329	Pharyngeal Neoplasms	3.4%
330	Central Nervous System Cysts	3.3%
331	Bile Duct Neoplasms	3.3%
332	gallbladder neoplasm	3.3%
333	Intestinal Neoplasms	3.3%
334	Penile Neoplasms	3.3%
335	Prostatic Neoplasms	3.3%
336	Stomach Neoplasms	3.3%
337	Zollinger-Ellison syndrome	3.3%
338	Polycythemia Vera	3.2%
339	Bronchial Neoplasms	3%
340	Multiple Pulmonary Nodules	3%
341	Laryngeal neoplasm	3%
342	Supratentorial Neoplasms	3%
343	Endometrial Neoplasms	2.9%
344	Bladder Neoplasm	2.9%
345	Kidney Neoplasm	2.9%
346	Ureteral Neoplasms	2.9%
347	Urethral Neoplasms	2.9%
348	Hypopharyngeal Neoplasms	2.6%
349	Pleural Effusion, Malignant	2.6%
350	Hypopharyngeal Cancer	2.6%
351	Brain Stem Neoplasms	2.5%
352	Parotid Neoplasms	2.5%
353	Prostatic Neoplasms, Castration-Resistant	2.5%
354	Nelson Syndrome	2.5%
355	Choroid Plexus Papilloma	2.3%
356	Cecal Neoplasms	2.2%
357	Duodenal Neoplasms	2.2%
358	Tonsillar Neoplasms	2.2%
359	Cerebellar Neoplasms	2.2%
360	Nasopharyngeal Neoplasms	2%
361	Colorectal Neoplasms	2%
362	Radicular Cyst	1.9%
363	Appendiceal Neoplasms	1.9%
364	Colonic Neoplasms	1.9%
365	Rectal Neoplasms	1.9%
366	Paranasal Sinus Neoplasms	1.8%
367	Anus Neoplasms	1.5%
368	Sigmoid Neoplasms	1.5%
369	Maxillary Sinus Neoplasms	1.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234